Role of oral microbiome on oral cancers, a review

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 552-558

  Gholizadeh, Pourya ^a   Eslami, Hosein ^b   Yousefi, Mehdi ^b   Asgharzadeh, Mohammad ^c   Aghazadeh, Mohammad ^d   Kafil, Hossein Samadi ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Host pathogen interactions; Inflammation; Oral cancer; Oral microbiome; Periodontitis

Indexed keywords

APOPTOSIS; ASSOCIATION; CANCER INCIDENCE; CANDIDA; CARCINOGENESIS; CHRONIC PERIODONTITIS; FUSOBACTERIUM INFECTION; FUSOBACTERIUM NUCLEATUM; HUMAN; IMMUNE RESPONSE; MOUSE; MOUTH CANCER; MOUTH CAVITY; MOUTH FLORA; MOUTH LESION; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; PORPHYROMONAS GINGIVALIS; PREVOTELLA; PREVOTELLA GINGIVALIS; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL; REVIEW; THRUSH; TISSUE INJURY; TONGUE EPITHELIUM; ANIMAL; CELL TRANSFORMATION; CLASSIFICATION; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUTH; MOUTH NEOPLASMS; PATHOGENICITY; PATHOLOGY; PERIODONTITIS; RISK FACTOR;

ANIMALS; CANDIDA; CELL TRANSFORMATION, NEOPLASTIC; FUSOBACTERIUM NUCLEATUM; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIOTA; MOUTH; MOUTH NEOPLASMS; PERIODONTITIS; PREVOTELLA; RISK FACTORS;

EID: 84989235047     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.09.082     Document Type: Review

References (87)

1. [1] Preza, D., Olsen, I., Willumsen, T., Boches, S.K., Cotton, S.L., Grinde, B., Paster, B.J., Microarray analysis of the microflora of root caries in elderly. Eur. J. Clin. Microbiol. Infect. Dis. 28:5 (2009), 509–517.
2. [2] Abiko, Y., Sato, T., Mayanagi, G., Takahashi, N., Profiling of subgingival plaque biofilm microflora from periodontally healthy subjects and from subjects with periodontitis using quantitative real‐time PCR. J. Periodontal Res. 45:3 (2010), 389–395.
3. [3] Meurman, J., Oral microbiota and cancer. J. Oral Microbiol., 2, 2010.
4. [4] Correa, P., Haenszel, W., Cuello, C., Tannenbaum, S., Archer, M., A model for gastric cancer epidemiology. Lancet 306:7924 (1975), 58–60.
5. [5] Lax, A.J., Thomas, W., How bacteria could cause cancer: one step at a time. Trends Microbiol. 10:6 (2002), 293–299.
6. [6] Hooper, S.J., Wilson, M.J., Crean, S.J., Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck 31:9 (2009), 1228–1239.
7. [7] Colombo, A.P.V., Boches, S.K., Cotton, S.L., Goodson, J.M., Kent, R., Haffajee, A.D., Socransky, S.S., Hasturk, H., Van Dyke, T.E., Dewhirst, F., Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. J. Periodontol. 80:9 (2009), 1421–1432.
8. [8] Duran-Pinedo, A.E., Chen, T., Teles, R., Starr, J.R., Wang, X., Krishnan, K., Frias-Lopez, J., Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis. ISME J. 8:8 (2014), 1659–1672.
9. [9] Bullon, P., Newman, H.N., Battino, M., Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: a shared pathology via oxidative stress and mitochondrial dysfunction?. Periodontology 2000 64:1 (2014), 139–153.
10. [10] Johannsen, A., Susin, C., Gustafsson, A., Smoking and inflammation: evidence for a synergistic role in chronic disease. Periodontology 2000 64:1 (2014), 111–126.
11. [11] Dewhirst, F.E., Chen, T., Izard, J., Paster, B.J., Tanner, A.C., Yu, W.-H., Lakshmanan, A., Wade, W.G., The human oral microbiome. J. Bacteriol. 192:19 (2010), 5002–5017.
12. [12] Jenkinson, H.F., Lamont, R.J., Oral microbial communities in sickness and in health. Trends Microbiol. 13:12 (2005), 589–595.
13. [13] Tezal, M., Sullivan, M.A., Hyland, A., Marshall, J.R., Stoler, D., Reid, M.E., Loree, T.R., Rigual, N.R., Merzianu, M., Hauck, L., Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol. Biomark. Prev. 18:9 (2009), 2406–2412.
14. [14] Fitzpatrick, S.G., Katz, J., The association between periodontal disease and cancer: a review of the literature. J. Dent. 38:2 (2010), 83–95.
15. [15] Yao, Q.-W., Zhou, D.-S., Peng, H.-J., Ji, P., Liu, D.-S., Association of periodontal disease with oral cancer: a meta-analysis. Tumor Biol. 35:7 (2014), 7073–7077.
16. [16] Hajishengallis, G., Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 35:1 (2014), 3–11.
17. [17] Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics. CA Cancer J. Clin. 61:2 (2011), 69–90.
18. [18] Shiboski, C.H., Schmidt, B.L., Jordan, R.C., Tongue and tonsil carcinoma. Cancer 103:9 (2005), 1843–1849.
19. [19] Sahingur, S.E., Yeudall, W.A., Chemokine function in periodontal disease and oral cavity cancer. Front. Immunol., 6, 2015.
20. [20] Schmidt, B.L., Dierks, E.J., Homer, L., Potter, B., Tobacco smoking history and presentation of oral squamous cell carcinoma. J. Oral Maxillofac. Surg. 62:9 (2004), 1055–1058.
21. [21] Gillison, M.L., Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Seminars in Oncology, 2004, Elsevier, 744–754.
22. [22] Network, C.G.A., Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517:7536 (2015), 576–582.
23. [23] Mager, D., Haffajee, A., Devlin, P., Norris, C., Posner, M., Goodson, J., The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J. Transl. Med., 3(1), 2005, 27.
24. [24] Nagy, K., Sonkodi, I., Szöke, I., Nagy, E., Newman, H., The microflora associated with human oral carcinomas. Oral Oncol. 34:4 (1998), 304–308.
25. [25] Hill, R.P., Tannock, I., The Basic Science of Oncology. 1987, Pergamon Press.
26. [26] Dwivedi, P., Mallya, S., Dongari-Bagtzoglou, A., A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia. Med. Mycol. 47:2 (2009), 157–167.
27. [27] Garro, A., Lieber, C., Alcohol and cancer. Annu. Rev. Pharmacol. Toxicol. 30:1 (1990), 219–249.
28. [28] Davidson, B.J., Hsu, T., Schantz, S.P., The genetics of tobacco-induced malignancy. Arch. Otolaryngol. Head Neck Surg. 119:11 (1993), 1198–1205.
29. [29] Laan, M., Bozinovski, S., Anderson, G.P., Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J. Immunol. 173:6 (2004), 4164–4170.
30. [30] Han, Y., Houcken, W., Loos, B., Schenkein, H., Tezal, M., Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer. Adv. Dent. Res. 26:1 (2014), 47–55.
31. [31] Scannapieco, F., Ng, P., Hovey, K., Hausmann, E., Hutson, A., Wactawski-Wende, J., Salivary biomarkers associated with alveolar bone loss. Ann. N. Y. Acad. Sci., 1098, 2007, 496.
32. [32] Abnet, C.C., Qiao, Y.-L., Dawsey, S.M., Dong, Z.-W., Taylor, P.R., Mark, S.D., Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int. J. Epidemiol. 34:2 (2005), 467–474.
33. [33] Michaud, D.S., Joshipura, K., Giovannucci, E., Fuchs, C.S., A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J. Natl. Cancer Inst. 99:2 (2007), 171–175.
34. [34] Hiraki, A., Matsuo, K., Suzuki, T., Kawase, T., Tajima, K., Teeth loss and risk of cancer at 14 common sites in Japanese. Cancer Epidemiol. Biomark. Prev. 17:5 (2008), 1222–1227.
35. [35] Nair, P., Sutherland, G., Palmer, R., Wilson, R., Scott, D., Gingival bleeding on probing increases after quitting smoking. J. Clin. Periodontol. 30:5 (2003), 435–437.
36. [36] Engberts, M., Vermeulen, C., Verbruggen, B., Van Haaften, M., Boon, M., Heintz, A., Candida and squamous (pre) neoplasia of immigrants and Dutch women as established in population-based cervical screening. Int. J. Gynecol. Cancer 16:4 (2006), 1596–1600.
37. [37] Firth, N., O'Grady, J., Reade, P., Oral squamous cell carcinoma in a young person with candidosis endocrinopathy syndrome: a case report. Int. J. Oral Maxillofac. Surg. 26:1 (1997), 42–44.
38. [38] Teles, R., Teles, F., Frias‐Lopez, J., Paster, B., Haffajee, A., Lessons learned and unlearned in periodontal microbiology. Periodontology 2000 62:1 (2013), 95–162.
39. [39] Domingues-Ferreira, M., Grumach, A.S., Duarte, A.J.D.S., De Moraes-Vasconcelos, D., Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer?. Med. Mycol. 47:2 (2009), 201–205.
40. [40] Jepsen, A., Winther, J., Mycotic infection in oral leukoplakia. Acta Odontol. Scand. 23:3 (1965), 239–256.
41. [41] Van der Waal, I., Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 45:4 (2009), 317–323.
42. [42] McCullough, M., Jaber, M., Barrett, A., Bain, L., Speight, P., Porter, S., Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol. 38:4 (2002), 391–393.
43. [43] Baqui, A., Meiller, T.F., Chon, J.J., Turng, B.-F., Falkler, W.A., Granulocyte-macrophage colony-stimulating factor amplification of interleukin-1β and tumor necrosis factor alpha production in THP-1 human monocytic cells stimulated with lipopolysaccharide of oral microorganisms. Clin. Diagn. Lab. Immunol. 5:3 (1998), 341–347.
44. [44] Gemmell, E., Seymour, G., Interleukin 1, interleukin 6 and transforming growth factor-β production by human gingival mononuclear cells following stimulation with Porphyromonas gingivalis and Fusobacterium nucleatum. J. Periodontal Res. 28:2 (1993), 122–129.
45. [45] Hönig, J., Rordorf-Adam, C., Siegmund, C., Wiedemann, W., Erard, F., Increased interleukin-1 beta (IL-1β) concentration in gingival tissue from periodontitis patients. J. Periodontal Res. 24:6 (1989), 362–367.
46. [46] M. Gowen, D.D. Wood, E.J. Ihrie, M.K. McGuire, R.G.G. Russell. An interleukin 1 like factor stimulates bone resorption in vitro 306 (5941), 1983, 378–380.
47. [47] Mochan, E., Armor, L., Sporer, R., Interleukin 1 stimulation of plasminogen activator production in cultured gingival fibroblasts. J. Periodontal Res. 23:1 (1988), 28–32.
48. [48] Sato, K., Fujii, Y., Kasono, K., Saji, M., Tsushima, T., Shizume, K., Stimulation of prostaglandin E2 and bone resorption by recombinant human interleukin 1 alpha in fetal mouse bones. Biochem. Biophys. Res. Commun. 138:2 (1986), 618–624.
49. [49] Brouckaert, P., Libert, C., Everaerdt, B., Takahashi, N., Cauwels, A., Fiers, W., Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology 187:3 (1993), 317–329.
50. [50] Dinarello, C.A., Cannon, J.G., Wolff, S.M., Bernheim, H.A., Beutler, B., Cerami, A., Figari, I., Palladino, M., O'connor, J., Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163:6 (1986), 1433–1450.
51. [51] Fujiwara, T., Ogawa, T., Sobue, S., Hamada, S., Chemical, immunobiological and antigenic characterizations of lipopolysaccharides from Bacteroides gingivalis strains. Microbiology 136:2 (1990), 319–326.
52. [52] Mao, S., Park, Y., Hasegawa, Y., Tribble, G.D., James, C.E., Handfield, M., Stavropoulos, M.F., Yilmaz, Ö., Lamont, R.J., Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cell. Microbiol. 9:8 (2007), 1997–2007.
53. [53] Yilmaz, Ö., Jungas, T., Verbeke, P., Ojcius, D.M., Activation of the phosphatidylinositol 3-kinase/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas gingivalis. Infect. Immun. 72:7 (2004), 3743–3751.
54. [54] Yao, L., Jermanus, C., Barbetta, B., Choi, C., Verbeke, P., Ojcius, D., Yilmaz, Ö., Porphyromonas gingivalis infection sequesters pro-apoptotic Bad through Akt in primary gingival epithelial cells. Mol. Oral Microbiol. 25:2 (2010), 89–101.
55. [55] Yilmaz, Ö., Yao, L., Maeda, K., Rose, T.M., Lewis, E.L., Duman, M., Lamont, R.J., Ojcius, D.M., ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis. Cell. Microbiol. 10:4 (2008), 863–875.
56. [56] Aymeric, L., Apetoh, L., Ghiringhelli, F., Tesniere, A., Martins, I., Kroemer, G., Smyth, M.J., Zitvogel, L., Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res. 70:3 (2010), 855–858.
57. [57] Kuboniwa, M., Hasegawa, Y., Mao, S., Shizukuishi, S., Amano, A., Lamont, R.J., Yilmaz, Ö., P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect. 10:2 (2008), 122–128.
58. [58] Groeger, S., Domann, E., Gonzales, J.R., Chakraborty, T., Meyle, J., B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology 216:12 (2011), 1302–1310.
59. [59] Inaba, H., Sugita, H., Kuboniwa, M., Iwai, S., Hamada, M., Noda, T., Morisaki, I., Lamont, R.J., Amano, A., Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell. Microbiol. 16:1 (2014), 131–145.
60. [60] Hamada, S., Koga, T., Nishihara, T., Fujiwara, T., Okahashi, N., Characterization and immunobiologic activities of lipopolysaccharides from periodontal bacteria. Adv. Dent. Res. 2:2 (1988), 284–291.
61. [61] Fischman, S., Revach, B., Bulvik, R., Maliutina, A., Rubinstein, A., Nussbaum, G., Elkin, M., Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget 6:26 (2015), 22613–22623.
62. [62] Rakoff-Nahoum, S., Medzhitov, R., Toll-like receptors and cancer. Nat. Rev. Cancer 9:1 (2009), 57–63.
63. [63] Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G., Han, Y.W., Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14:2 (2013), 195–206.
64. [64] Ahn, J., Segers, S., Hayes, R.B., Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis, 2012, bgs112.
65. [65] Pihlstrom, B.L., Michalowicz, B.S., Johnson, N.W., Periodontal diseases. Lancet 366:9499 (2005), 1809–1820.
66. [66] Loesche, W.J., Grossman, N.S., Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin. Microbiol. Rev. 14:4 (2001), 727–752.
67. [67] Champagne, C.M., Buchanan, W., Reddy, M.S., Preisser, J.S., Beck, J.D., Offenbacher, S., Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontology 2000 31:1 (2003), 167–180.
68. [68] Scannapieco, F.A., Wang, B., Shiau, H.J., Oral bacteria and respiratory infection: effects on respiratory pathogen adhesion and epithelial cell proinflammatory cytokine production. Ann. Periodontol. 6:1 (2001), 78–86.
69. [69] Paju, S., Scannapieco, F., Oral biofilms, periodontitis, and pulmonary infections. Oral Dis. 13:6 (2007), 508–512.
70. [70] Brown, J., Oral biofilms, periodontitis and pulmonary infections. Oral Dis. 13:6 (2007), 513–514.
71. [71] Nichols, T.C., Fischer, T.H., Deliargyris, E.N., Baldwin, A.S. Jr., Role of nuclear factor-kappa B (NF-κB) in inflammation, periodontitis, and atherogenesis. Ann. Periodontol. 6:1 (2001), 20–29.
72. [72] Lopez, N.J., Da Silva, I., Ipinza, J., Gutiérrez, J., Periodontal therapy reduces the rate of preterm low birth weight in women with pregnancy-associated gingivitis. J. Periodontol. 76:11-s (2005), 2144–2153.
73. [73] D'Aiuto, F., Parkar, M., Andreou, G., Suvan, J., Brett, P.M., Ready, D., Tonetti, M.S., Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J. Dent. Res. 83:2 (2004), 156–160.
74. [74] Tezal, M., Nasca, M.S., Stoler, D.L., Melendy, T., Hyland, A., Smaldino, P.J., Rigual, N.R., Loree, T.R., Chronic periodontitis- human papillomavirus synergy in base of tongue cancers. Arch. Otolaryngol. Head Neck Surg. 135:4 (2009), 391–396.
75. [75] Tezal, M., Grossi, S.G., Genco, R.J., Is periodontitis associated with oral neoplasms?. J. Periodontol. 76:3 (2005), 406–410.
76. [76] Scott, D., Singer, D., Suppression of overt gingival inflammation in tobacco smokers–clinical and mechanistic considerations. Int. J. Dent. Hyg. 2:3 (2004), 104–110.
77. [77] Costa, F.O., Susin, C., Cortelli, J.R., Pordeus, I.A., Epidemiology of periodontal disease. Int. J. Dent., 2012, 2012.
78. [78] Hormia, M., Willberg, J., Ruokonen, H., Syrjänen, S., Marginal periodontium as a potential reservoir of human papillomavirus in oral mucosa. J. Periodontol. 76:3 (2005), 358–363.
79. [79] Saygun, I., Kubar, A., Özdemir, A., Slots, J., Periodontitis lesions are a source of salivary cytomegalovirus and Epstein–Barr virus. J. Periodontal Res. 40:2 (2005), 187–191.
80. [80] D'Souza, G., Kreimer, A.R., Viscidi, R., Pawlita, M., Fakhry, C., Koch, W.M., Westra, W.H., Gillison, M.L., Case–control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356:19 (2007), 1944–1956.
81. [81] Goswami, B., Rajappa, M., Sharma, M.A., Sharma, A., Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies. Int. J. Gynecol. Cancer 18:4 (2008), 591–599.
82. [82] Hajishengallis, G., Lamont, R.J., Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol. Oral Microbiol. 27:6 (2012), 409–419.
83. [83] Katz, J., Onate, M.D., Pauley, K.M., Bhattacharyya, I., Cha, S., Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int. J. Oral Sci., 3(4), 2011, 209.
84. [84] McCoy, A.N., Araujo-Perez, F., Azcarate-Peril, A., Yeh, J.J., Sandler, R.S., Keku, T.O., Fusobacterium is associated with colorectal adenomas. PLoS One, 8(1), 2013, e53653.
85. [85] Kostic, A.D., Gevers, D., Pedamallu, C.S., Michaud, M., Duke, F., Earl, A.M., Ojesina, A.I., Jung, J., Bass, A.J., Tabernero, J., Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22:2 (2012), 292–298.
86. [86] Rakoff-Nahoum, S., Why cancer and inflammation. Yale J. Biol. Med. 79:3–4 (2006), 123–130.
87. [87] Han, Y., Wang, X., Mobile microbiome oral bacteria in extra-oral infections and inflammation. J. Dent. Res. 92:6 (2013), 485–491, 10.1177/0022034513487559.